[1]
J. P. Thyssen, “Abrocitinib Reduces Skin Pain in Adolescent and Adult Patients With Moderate-to-Severe Atopic Dermatitis”,
J of Skin
, vol. 7, no. 2, p. s151, Mar. 2023.